CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.60−0.01 (-1.15%)
Close on Nov 18, 2026Market cap $16.09MP/E –Yield –
CVRx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
CVRx's shares outstanding was 27M at Jun 30, 2026. For fiscal 2025 it was 26M, up 15.4% from the year before. The highest annual figure on record is 26M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26M | +15.4% |
| FY2024 | Dec 31, 2024 | 23M | +8.9% |
| FY2023 | Dec 31, 2023 | 21M | +1.1% |
| FY2022 | Dec 31, 2022 | 21M | +98.2% |
| FY2021 | Dec 31, 2021 | 10M | +2576.4% |
| FY2020 | Dec 31, 2020 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 27M | +1.7% |
| Q1 FY2026 | Mar 31, 2026 | 26M | +1.9% |
| Q4 FY2025 | Dec 31, 2025 | 26M | +6.0% |
| Q3 FY2025 | Sep 30, 2025 | 26M | +14.9% |
| Q2 FY2025 | Jun 30, 2025 | 26M | +20.5% |
| Q1 FY2025 | Mar 31, 2025 | 26M | +21.9% |
| Q4 FY2024 | Dec 31, 2024 | 25M | +18.7% |
| Q3 FY2024 | Sep 30, 2024 | 23M | +9.5% |
| Q2 FY2024 | Jun 30, 2024 | 22M | +4.4% |
| Q1 FY2024 | Mar 31, 2024 | 21M | +2.6% |
| Q4 FY2023 | Dec 31, 2023 | 21M | +1.1% |
| Q3 FY2023 | Sep 30, 2023 | 21M | +1.1% |
| Q2 FY2023 | Jun 30, 2023 | 21M | +1.0% |
| Q1 FY2023 | Mar 31, 2023 | 21M | +1.2% |
| Q4 FY2022 | Dec 31, 2022 | 21M | +0.4% |
| Q3 FY2022 | Sep 30, 2022 | 21M | +2.2% |
| Q2 FY2022 | Jun 30, 2022 | 21M | +5501.5% |
| Q1 FY2022 | Mar 31, 2022 | 20M | +5570.9% |
| Q4 FY2021 | Dec 31, 2021 | 21M | +5596.5% |
| Q3 FY2021 | Sep 30, 2021 | 20M | +5485.2% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +1.6% |
| Q1 FY2021 | Mar 31, 2021 | 0M | – |
| Q4 FY2020 | Dec 31, 2020 | 0M | – |
| Q3 FY2020 | Sep 30, 2020 | 0M | – |
| Q2 FY2020 | Jun 30, 2020 | 0M | – |
See a number that looks wrong?